Investor Relations Home

There are no items to display.

Stock Quote

MASI (Common Stock)
Exchange
Price
Change (%)
Volume
Data as of Copyright Nasdaq. Minimum 15 minutes delayed.

Online Investor Kit

	Masimo Reports First Quarter 2017 Financial Results
	2016 Annual Report
	2016 Form 10K
	2017 Proxy Statement
	2017 Proxy Statement Supplement No.1
	2017 Proxy Statement Supplement No. 2

Corporate Profile

We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... More >>

Upcoming Events

More >>

There are currently no events to display.

Recent News

RSS Feeds | More >>

05/14/08

Summary Toggle Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin IRVINE, Calif., May 14 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion-and-Low-Perfusion pulse oximetry, today announced it has received FDA clearance for its breakthrough noninvasive and continuous total hemoglobin monitoring technology (SpHb(TM)).
05/09/08

Summary Toggle Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry Hospital-wide conversion achieves technology and sensor standardization, creates process efficiencies and reduces costs IRVINE, Calif., May 9 /PRNewswire-FirstCall/ -- Saint Barnabas Medical Center and Masimo, the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion Pulse Oxime
05/06/08

Summary Toggle Masimo Showcases Best-in-Class Patient Safety Solutions at the AACN Conference Masimo introduces the new Rad-87 Pulse CO-Oximeter, Patient SafetyNet, and noninvasive hemoglobin IRVINE, Calif., May 6 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion Pulse Oximetry, will showcase the latest technology for patient saf
05/01/08

Summary Toggle Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference IRVINE, Calif., May 1, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry-and-Measure-Through-Motion- and-Low-Perfusion pulse oximetry, today announced that it is scheduled to present at the Deutsche Bank 33rd Annual Health Car
04/29/08

Summary Toggle Masimo Reports First Quarter 2008 Financial Results Record results mark 19th consecutive quarter of revenue growth Q1 2008 Highlights: - Product revenues increased 30% to a record $59.7 million - Shipped 28,600 new pulse oximeters - Rainbow revenues increased 104% IRVINE, Calif., April 29, 2008 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MA
04/18/08

Summary Toggle Masimo to Report First Quarter 2008 Financial Results on April 29, 2008 Conference call and webcast with Masimo CEO and CFO to begin after markets close at 2:00 p.m. PT (5:00 p.m.
04/16/08

Summary Toggle Atom Medical Adopts Masimo Rainbow SET Technology IRVINE, Calif., April 16, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced an agreement with Atom Medical Corporation, a leading global manufacturer of neonatal
04/03/08

Summary Toggle Masimo PVI(TM) Cleared for Market in Japan PVI could help clinicians assess a patient's fluid responsiveness noninvasively, according to a new study published in 'Anesthesia & Analgesia' IRVINE, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetr
03/25/08

Summary Toggle Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide IRVINE, Calif., March 25, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, today announced an agreement with Switzerland-based Schiller, a leading European manufacturer and sup
03/19/08

Summary Toggle New Study Finds Masimo Rainbow SET Pulse CO-Oximetry(TM) Effective as a Universal Screening Tool to Identify Cases of Unsuspected CO Poisoning in ERs Rhode Island Hospital study identifies 11 cases of unsuspected CO poisoning through universal CO screening with the Masimo Rad-57 Pulse CO-Oximeter(TM) IRVINE, Calif., March 19 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry and Measure-Through-Motion & Low Perfusion Pulse Oximet

Receive E-mail Alerts

To request a copy of the Annual Report, click here .